Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine versus morphine as adjuvants to bupivacaine for labor analgesia
PACTR202412669162158Phase 3Completed
- Sponsor
- Al-Azhar University
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine, morphine and bupivacaine in labor pain (2 arms), sponsored by Al-Azhar University. Primary endpoints: Pain intensity change on visual analog scale and Duration of analgesia. Started Nov 2023; status: completed.
02
Drugs
dexmedetomidinemorphinebupivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on PACTR202412669162158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412669162158.